Wednesday 29 June 2022, 4pm to 6pm – virtual
All patients referred into our supraregional unit are discussed in a multidisciplinary (MDT) meeting. This event is to share how the MDT functions with the opportunity to discuss cases from which we can all learn in an 'open MDT' meeting. General topics including areas of research and new developments will also be covered.
This event is aimed at multidisciplinary healthcare professionals, who care, and/or refer cutaneous T-cell lymphoma (CTCL) patients to The Christie within the North West region, including dermatologists, clinical oncologists, haematologists, histopathologists, clinical trainees, radiotherapy staff and nurses.
|
Time |
Session |
|---|---|
|
4.00pm |
Welcome |
|
4.05pm |
An introduction to the MDT members and their roles. An explanation of how the MDT is run at The Christie, illustrating the patient pathway through diagnosis and into management |
|
4.35pm |
Newly approved therapies in CTCL |
|
4.50pm |
Clinical trials available for patients at The Christie |
|
5.00pm |
Comfort Break |
|
5.10pm |
Case Presentations highlighting diagnostic challenges and management decisions |
|
5.50pm |
Questions for the panel |
|
6.00pm |
Close of meeting |
Speakers to include:
This educational meeting is organised by The Christie School of Oncology and funded by Kyowa Kirin Ltd.
Sign up to our education events mailing list to be kept up to date with this and future events
© 2023 The Christie NHS Foundation Trust
The Christie Charity